Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Newcastle disease virus + infectious bronchitis virus + egg drop syndrome virus + H9 avian influenza virus inactivated vaccine (Youbang Pharmaceutical)
- Development stage
- Unknown
- Lead developer
- Youbang Pharmaceutical
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Intramuscular, Subcutaneous
01
Overview
Newcastle disease virus + infectious bronchitis virus + egg drop syndrome virus + H9 avian influenza virus inactivated vaccine is a quadrivalent veterinary vaccine developed by Youbang Pharmaceutical. It is designed to protect poultry against four significant viral diseases: Newcastle disease, infectious bronchitis, egg drop syndrome, and H9 subtype avian influenza. The vaccine utilizes inactivated viral antigens, typically combined with an oil adjuvant to enhance the immune response. Upon administration, it stimulates the production of specific antibodies against the Newcastle disease virus (NDV), infectious bronchitis virus (IBV), egg drop syndrome virus (EDSV), and H9 subtype avian influenza virus (AIV), thereby providing broad-spectrum protection and reducing the economic impact of these diseases in commercial poultry flocks.
- Other names
- 鸡新城疫、传染性支气管炎、减蛋综合征、禽流感(H9亚型)四联灭活疫苗NDV+IBV+EDS+H9 AI quadrivalent inactivated vaccine
02
Targets
H9 HA (Influenza A hemagglutinin H9)
Beyond the preview
Go deeper on Newcastle disease virus + infectious bronchitis virus + egg drop syndrome virus + H9 avian influenza virus inactivated vaccine (Youbang Pharmaceutical).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Newcastle disease virus + infectious bronchitis virus + egg drop syndrome virus + H9 avian influenza virus inactivated vaccine (Youbang Pharmaceutical).